Matthias is a Director in McKinsey’s Hamburg office and co-leader of the Global Pharmaceuticals and Medical Products (PMP) R&D and Medical Practice. Since joining the Firm in 2002, Matthias engaged with pharmaceuticals clients in EU but also in the US and in Asia transforming R&D organizations to overcome innovation and productivity issues through deep-rooted transformatory approaches. His focus has been on critical junctures and capabilities in early clinical development and in the late-stage clinical, medical, and exploring the value of big data / advanced analytics in the trial and real-world setting. In addition, he has engaged in translating learnings between innovator and generics R&D (e.g., on biosimilars) as well as supporting a cross-industry dialog on drug innovation. Matthias holds a Ph.D. in Chemistry/Biochemistry from the University of Bochum with a particular focus on Neuroscience. Before his career with McKinsey, he worked as a Research Associate and Postdoctorate at a Center for Molecular Neurobiology in Hamburg. He authored several articles in the field of bioinformatics and molecular biology.